Appleton Partners’s Elevance Health ELV Stock Holding History

Appleton Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-401	Closed	-$206K	–	302
2022 Q4	$206K	Buy	+401	New	+$204K	0.02%	292
2022 Q2	–	Sell	-425	Closed	-$209K	–	298
2022 Q1	$209K	Sell	425 -61	-13%	-$27.9K	0.02%	298
2021 Q4	$225K	Sell	486 -59	-11%	-$24.8K	0.02%	295
2021 Q3	$203K	Sell	545 -210	-28%	-$79.8K	0.02%	288
2021 Q2	$288K	Sell	755 -5	-0.7%	-$1.91K	0.02%	255
2021 Q1	$273K	Hold	760	–	–	0.03%	250
2020 Q4	$244K	Hold	760	–	–	0.02%	252
2020 Q3	$204K	Sell	760 -10	-1%	-$2.69K	0.02%	257
2020 Q2	$202K	Buy	+770	New	+$205K	0.02%	250
2020 Q1	–	Sell	-801	Closed	-$242K	–	266
2019 Q4	$242K	Buy	+801	New	+$220K	0.03%	268
2019 Q3	–	Sell	-821	Closed	-$232K	–	281
2019 Q2	$232K	Buy	821 +21	+3%	+$5.74K	0.03%	260
2019 Q1	$230K	Buy	+800	New	+$231K	0.03%	247

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Appleton Partners's ELV Position: Q1 2023 in Review

Appleton Partners sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 401 shares — an estimated $206K sold.

Appleton Partners first reported a position in ELV in Q1 2019 and held it in 12 quarters. The position peaked at $288K in Q2 2021. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

Appleton Partners reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
Appleton Partners sold 401 Elevance Health shares in Q1 2023, an estimated $206K.
Appleton Partners first reported a position in Elevance Health in Q1 2019 and held it in 12 quarters.
Appleton Partners's Elevance Health position peaked at $288K in Q2 2021.
1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Appleton Partners's 13F filing for Q1 2023, filed 10 Apr 2023.